Catching up with the co-founders of Amylyx on the launch of their ALS treatment
- blonca9
- Aug 15, 2023
- 1 min read
Josh Cohen and Justin Klee provide an update on the launch of RELYVRIO, discuss the PHOENIX P3 trial, and reflect on the roller coaster of the last year.